NYSE

An artificial intelligence startup that makes collars for cows is about to be worth more than $2 billion…

It’s not hard to find healthcare stocks, including small-cap biotech companies, trading below $50 per share. However, many…

Could your portfolio use some more exposure to the healthcare sector as well as more income? If so,…

Eli Lilly‘s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…

There hasn’t been a lot of insider buying from executives and directors at artificial intelligence (AI) companies recently,…

BigBear.ai has stumbled since its market debut. It’s struggling to expand beyond its niche government market. IBM’s scale…

This drug company offers a decent balance of risk and reward, with a 4.6% yield and a payout…

Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…

One of the ways lenders are restricted from allowing Australians to take on too much debt is that,…

We’ve received this fact sheet of the “initial pipeline” of the US-Australia critical minerals and rare earths framework:…

Daily trading activity on Wall Street has reached unprecedented levels, with the New York Stock Exchange now processing…

Australia: Mon: Zip (Q1 results), Beach Energy production update Tue: RBA Asst Governor Brad Jones speaks, BHP &…

Peter Thiel is betting big on a $2B AI cow collar startup powered by cowgorithms — and investors are fighting to get in